SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5vm9'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1AXW_B_MTXB733_1
(THYMIDYLATE SYNTHASE)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 11 ILE A 519
ASP A 538
GLY A 537
PHE A 506
TYR A 858
None
1.41A 1axwB-5vm9A:
undetectable
1axwB-5vm9A:
14.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IG3_A_VIBA502_1
(THIAMIN
PYROPHOSPHOKINASE)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 8 SER A 728
ASN A 730
GLN A 377
ASP A 375
None
1.12A 1ig3A-5vm9A:
5.0
1ig3B-5vm9A:
5.1
1ig3A-5vm9A:
14.77
1ig3B-5vm9A:
14.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JU6_A_LYAA317_1
(THYMIDYLATE SYNTHASE)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 11 ILE A 519
ASP A 538
GLY A 537
PHE A 506
TYR A 858
None
1.37A 1ju6A-5vm9A:
undetectable
1ju6A-5vm9A:
16.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JU6_C_LYAC315_1
(THYMIDYLATE SYNTHASE)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 10 ILE A 519
ASP A 538
GLY A 537
PHE A 506
TYR A 858
None
1.37A 1ju6C-5vm9A:
undetectable
1ju6C-5vm9A:
16.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JUJ_A_LYAA315_1
(THYMIDYLATE SYNTHASE)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 10 ILE A 519
ASP A 538
GLY A 537
PHE A 506
TYR A 858
None
1.36A 1jujA-5vm9A:
undetectable
1jujA-5vm9A:
16.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JUJ_B_LYAB315_1
(THYMIDYLATE SYNTHASE)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 10 ILE A 519
ASP A 538
GLY A 537
PHE A 506
TYR A 858
None
1.36A 1jujB-5vm9A:
undetectable
1jujB-5vm9A:
16.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JUJ_C_LYAC315_1
(THYMIDYLATE SYNTHASE)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 10 ILE A 519
ASP A 538
GLY A 537
PHE A 506
TYR A 858
None
1.36A 1jujC-5vm9A:
undetectable
1jujC-5vm9A:
16.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1JUJ_D_LYAD315_1
(THYMIDYLATE SYNTHASE)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 10 ILE A 519
ASP A 538
GLY A 537
PHE A 506
TYR A 858
None
1.36A 1jujD-5vm9A:
undetectable
1jujD-5vm9A:
16.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QD4_A_CHDA803_0
(FERROCHELATASE)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 5 LEU A 326
PRO A 327
LEU A 342
ILE A 232
None
0.66A 2qd4A-5vm9A:
5.3
2qd4A-5vm9A:
17.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VAV_F_CSCF1383_2
(ACETYL-COA--DEACETYL
CEPHALOSPORIN C
ACETYLTRANSFERASE)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
3 / 3 LEU A  33
MET A 406
MET A 211
None
1.06A 2vavF-5vm9A:
2.6
2vavF-5vm9A:
20.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y7H_B_SAMB530_1
(TYPE I RESTRICTION
ENZYME ECOKI M
PROTEIN)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
3 / 3 TYR A 226
GLU A 262
THR A 358
None
0.87A 2y7hB-5vm9A:
undetectable
2y7hB-5vm9A:
19.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PRS_A_RITA1001_1
(ENDOTHIAPEPSIN)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 10 ASP A 538
ILE A 593
LEU A 650
THR A 856
ILE A 575
None
1.22A 3prsA-5vm9A:
undetectable
3prsA-5vm9A:
18.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3R9V_B_DXCB323_0
(INVASIN IPAD)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 7 TRP A 452
ILE A 520
ILE A 522
VAL A 553
None
0.66A 3r9vA-5vm9A:
undetectable
3r9vB-5vm9A:
undetectable
3r9vA-5vm9A:
15.34
3r9vB-5vm9A:
15.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3W9T_F_W9TF512_1
(HEMOLYTIC LECTIN
CEL-III)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 6 THR A 600
GLY A 671
ASP A 670
ILE A 800
None
0.98A 3w9tF-5vm9A:
undetectable
3w9tF-5vm9A:
19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A7A_B_RGZB601_1
(AMINE OXIDASE
[FLAVIN-CONTAINING]
B)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 12 LEU A 780
LEU A 783
LEU A 787
CYH A 788
ILE A 666
None
0.80A 4a7aB-5vm9A:
undetectable
4a7aB-5vm9A:
20.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4F3T_A_IPHA901_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 4 PHE A 588
VAL A 592
ALA A 621
PHE A 654
None
0.42A 4f3tA-5vm9A:
59.9
4f3tA-5vm9A:
79.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4F3T_A_IPHA902_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 6 LEU A 651
LYS A 661
LEU A 695
GLU A 696
TYR A 699
None
0.75A 4f3tA-5vm9A:
59.9
4f3tA-5vm9A:
79.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4F3T_A_IPHA902_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 6 LEU A 651
TYR A 655
LYS A 661
LEU A 695
GLU A 696
None
0.90A 4f3tA-5vm9A:
59.9
4f3tA-5vm9A:
79.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F4D_B_CHDB504_0
(FERROCHELATASE,
MITOCHONDRIAL)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 4 LEU A 326
PRO A 327
LEU A 342
ILE A 232
None
0.72A 4f4dB-5vm9A:
4.4
4f4dB-5vm9A:
17.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FOX_E_D16E301_1
(THYMIDYLATE SYNTHASE)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 12 ILE A 519
ASP A 538
GLY A 537
PHE A 506
TYR A 858
None
1.32A 4foxE-5vm9A:
undetectable
4foxE-5vm9A:
14.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FOX_F_D16F301_1
(THYMIDYLATE SYNTHASE)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 11 ILE A 519
ASP A 538
GLY A 537
PHE A 506
TYR A 858
None
1.29A 4foxF-5vm9A:
undetectable
4foxF-5vm9A:
14.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FOX_H_D16H301_1
(THYMIDYLATE SYNTHASE)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 11 ILE A 519
ASP A 538
GLY A 537
PHE A 506
TYR A 858
None
1.31A 4foxH-5vm9A:
undetectable
4foxH-5vm9A:
14.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HVR_A_SALA203_1
(3-HYDROXYANTHRANILAT
E 3,4-DIOXYGENASE)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 7 HIS A 767
ASP A 748
VAL A  17
GLU A 746
None
0.94A 4hvrA-5vm9A:
undetectable
4hvrA-5vm9A:
12.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KIC_B_SAMB401_0
(METHYLTRANSFERASE
MPPJ)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 12 ILE A 731
CYH A 718
GLY A 726
GLY A 729
ILE A 757
None
1.10A 4kicB-5vm9A:
undetectable
4kicB-5vm9A:
18.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4OLA_A_IPHA901_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 5 TYR A 655
LYS A 661
LEU A 695
GLU A 696
TYR A 699
None
0.88A 4olaA-5vm9A:
56.5
4olaA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4OLB_A_TRPA902_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 5 LYS A 661
LEU A 695
GLU A 696
TYR A 699
None
1.00A 4olbA-5vm9A:
59.1
4olbA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4OLB_A_TRPA902_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 5 TYR A 655
LYS A 661
LEU A 695
TYR A 699
None
0.91A 4olbA-5vm9A:
59.1
4olbA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4W5N_A_IPHA902_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
6 / 6 LEU A 651
ILE A 652
LYS A 661
LEU A 695
GLU A 696
TYR A 699
None
0.59A 4w5nA-5vm9A:
56.5
4w5nA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4W5O_A_IPHA904_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 7 CYH A 692
ILE A 693
PRO A 701
ILE A 703
ASP A 772
None
0.50A 4w5oA-5vm9A:
55.6
4w5oA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4W5O_A_IPHA905_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 4 TYR A 655
LYS A 661
GLU A 696
TYR A 699
None
0.92A 4w5oA-5vm9A:
55.6
4w5oA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4W5O_A_IPHA906_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 5 PHE A 588
PRO A 591
VAL A 592
ALA A 621
PHE A 654
None
0.36A 4w5oA-5vm9A:
55.6
4w5oA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4W5O_A_IPHA907_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 5 ALA A 544
LYS A 571
THR A 853
THR A 856
None
A  B   1 ( 2.9A)
None
None
0.71A 4w5oA-5vm9A:
55.6
4w5oA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4W5O_A_IPHA907_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 5 ALA A 544
LYS A 571
THR A 856
TYR A 858
None
A  B   1 ( 2.9A)
None
None
0.64A 4w5oA-5vm9A:
55.6
4w5oA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4W5Q_A_IPHA902_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 6 CYH A 692
ILE A 693
ILE A 703
ASP A 772
None
0.46A 4w5qA-5vm9A:
50.1
4w5qA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4W5Q_A_IPHA903_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 5 TYR A 655
LYS A 661
PRO A 662
LEU A 695
TYR A 699
None
0.77A 4w5qA-5vm9A:
50.1
4w5qA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4W5Q_A_IPHA904_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 4 PHE A 588
VAL A 592
ALA A 621
PHE A 654
None
0.33A 4w5qA-5vm9A:
50.1
4w5qA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4W5Q_A_IPHA905_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 6 ASP A 538
ALA A 544
LYS A 571
THR A 853
THR A 856
None
None
A  B   1 ( 2.9A)
None
None
0.73A 4w5qA-5vm9A:
50.1
4w5qA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4W5Q_A_IPHA905_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 6 ASP A 538
ALA A 544
LYS A 571
THR A 856
TYR A 858
None
None
A  B   1 ( 2.9A)
None
None
0.66A 4w5qA-5vm9A:
50.1
4w5qA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4W5R_A_IPHA903_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 4 TYR A 655
LYS A 661
GLU A 696
TYR A 699
None
0.92A 4w5rA-5vm9A:
58.3
4w5rA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4W5R_A_IPHA904_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 4 PHE A 588
VAL A 592
ALA A 621
PHE A 654
None
0.42A 4w5rA-5vm9A:
58.3
4w5rA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4W5R_A_IPHA905_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 6 ASP A 538
ALA A 544
LYS A 571
THR A 853
THR A 856
None
None
A  B   1 ( 2.9A)
None
None
0.77A 4w5rA-5vm9A:
58.3
4w5rA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4W5R_A_IPHA905_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 6 ASP A 538
ALA A 544
LYS A 571
THR A 856
TYR A 858
None
None
A  B   1 ( 2.9A)
None
None
0.70A 4w5rA-5vm9A:
58.3
4w5rA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4W5T_A_IPHA902_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 6 ARG A 689
ILE A 693
ILE A 703
ASP A 772
None
1.11A 4w5tA-5vm9A:
46.0
4w5tA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4W5T_A_IPHA902_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 6 CYH A 692
ILE A 693
ILE A 703
ASP A 772
None
0.43A 4w5tA-5vm9A:
46.0
4w5tA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4W5T_A_IPHA903_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 5 TYR A 655
LYS A 661
PRO A 662
GLU A 696
TYR A 699
None
0.81A 4w5tA-5vm9A:
46.0
4w5tA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4W5T_A_IPHA904_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 4 PHE A 588
VAL A 592
ALA A 621
PHE A 654
None
0.39A 4w5tA-5vm9A:
46.0
4w5tA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4W5T_A_IPHA905_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 6 ASP A 538
ALA A 544
LYS A 571
THR A 853
THR A 856
None
None
A  B   1 ( 2.9A)
None
None
0.69A 4w5tA-5vm9A:
46.0
4w5tA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4W5T_A_IPHA905_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 6 ASP A 538
ALA A 544
LYS A 571
THR A 856
TYR A 858
None
None
A  B   1 ( 2.9A)
None
None
0.66A 4w5tA-5vm9A:
46.0
4w5tA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z4C_A_IPHA903_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 6 ARG A 689
ILE A 693
ILE A 703
ASP A 772
None
1.14A 4z4cA-5vm9A:
55.3
4z4cA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z4C_A_IPHA903_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 6 CYH A 692
ILE A 693
ILE A 703
ASP A 772
None
0.49A 4z4cA-5vm9A:
55.3
4z4cA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z4C_A_IPHA904_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
6 / 6 TYR A 655
LYS A 661
PRO A 662
LEU A 695
GLU A 696
TYR A 699
None
0.77A 4z4cA-5vm9A:
55.3
4z4cA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z4C_A_IPHA905_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 5 PHE A 588
PRO A 591
VAL A 592
ALA A 621
PHE A 654
None
0.34A 4z4cA-5vm9A:
55.3
4z4cA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z4C_A_IPHA906_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 6 ASP A 538
ALA A 544
LYS A 571
THR A 853
THR A 856
None
None
A  B   1 ( 2.9A)
None
None
0.70A 4z4cA-5vm9A:
55.3
4z4cA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z4C_A_IPHA906_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 6 ASP A 538
ALA A 544
LYS A 571
THR A 856
TYR A 858
None
None
A  B   1 ( 2.9A)
None
None
0.66A 4z4cA-5vm9A:
55.3
4z4cA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z4D_A_IPHA902_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 6 ARG A 689
ILE A 693
ILE A 703
ASP A 772
None
1.15A 4z4dA-5vm9A:
55.7
4z4dA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z4D_A_IPHA902_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 6 CYH A 692
ILE A 693
ILE A 703
ASP A 772
None
0.47A 4z4dA-5vm9A:
55.7
4z4dA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z4D_A_IPHA903_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 5 TYR A 655
LYS A 661
LEU A 695
GLU A 696
TYR A 699
None
0.92A 4z4dA-5vm9A:
55.7
4z4dA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z4D_A_IPHA904_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 5 PHE A 588
PRO A 591
VAL A 592
ALA A 621
PHE A 654
None
0.36A 4z4dA-5vm9A:
55.7
4z4dA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z4D_A_IPHA905_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 5 ALA A 544
LYS A 571
THR A 853
THR A 856
None
A  B   1 ( 2.9A)
None
None
0.69A 4z4dA-5vm9A:
55.7
4z4dA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z4D_A_IPHA905_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 5 ALA A 544
LYS A 571
THR A 856
TYR A 858
None
A  B   1 ( 2.9A)
None
None
0.64A 4z4dA-5vm9A:
55.7
4z4dA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z4E_A_IPHA904_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 7 CYH A 692
ILE A 693
PRO A 701
ILE A 703
ASP A 772
None
0.51A 4z4eA-5vm9A:
55.6
4z4eA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z4E_A_IPHA905_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 4 TYR A 655
LYS A 661
GLU A 696
TYR A 699
None
0.89A 4z4eA-5vm9A:
55.6
4z4eA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z4E_A_IPHA906_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 5 PHE A 588
PRO A 591
VAL A 592
ALA A 621
PHE A 654
None
0.37A 4z4eA-5vm9A:
55.6
4z4eA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z4E_A_IPHA907_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 5 ALA A 544
LYS A 571
THR A 853
THR A 856
None
A  B   1 ( 2.9A)
None
None
0.69A 4z4eA-5vm9A:
55.6
4z4eA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z4E_A_IPHA907_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 5 ALA A 544
LYS A 571
THR A 856
TYR A 858
None
A  B   1 ( 2.9A)
None
None
0.65A 4z4eA-5vm9A:
55.6
4z4eA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z4F_A_IPHA902_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
7 / 7 LEU A 651
TYR A 655
LYS A 661
PRO A 662
LEU A 695
GLU A 696
TYR A 699
None
0.81A 4z4fA-5vm9A:
58.0
4z4fA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z4F_A_IPHA903_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 4 VAL A 592
ALA A 621
PHE A 654
THR A 658
None
0.39A 4z4fA-5vm9A:
58.0
4z4fA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z4F_A_IPHA904_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 6 ASP A 538
ALA A 544
LYS A 571
THR A 853
THR A 856
None
None
A  B   1 ( 2.9A)
None
None
0.69A 4z4fA-5vm9A:
58.0
4z4fA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z4F_A_IPHA904_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 6 ASP A 538
ALA A 544
LYS A 571
THR A 856
TYR A 858
None
None
A  B   1 ( 2.9A)
None
None
0.61A 4z4fA-5vm9A:
58.0
4z4fA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z4G_A_IPHA902_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 7 CYH A 692
ILE A 693
PRO A 701
ILE A 703
ASP A 772
None
0.49A 4z4gA-5vm9A:
55.6
4z4gA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z4G_A_IPHA903_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
6 / 6 LEU A 651
TYR A 655
LYS A 661
PRO A 662
GLU A 696
TYR A 699
None
0.74A 4z4gA-5vm9A:
55.6
4z4gA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z4G_A_IPHA904_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 4 PHE A 588
VAL A 592
ALA A 621
PHE A 654
None
0.33A 4z4gA-5vm9A:
55.6
4z4gA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z4G_A_IPHA905_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 5 ASP A 538
ALA A 544
THR A 853
THR A 856
None
0.73A 4z4gA-5vm9A:
55.6
4z4gA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z4G_A_IPHA905_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 5 ASP A 538
ALA A 544
THR A 856
TYR A 858
None
0.57A 4z4gA-5vm9A:
55.6
4z4gA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z4H_A_IPHA902_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 5 TYR A 655
LYS A 661
LEU A 695
GLU A 696
TYR A 699
None
0.82A 4z4hA-5vm9A:
55.9
4z4hA-5vm9A:
79.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z4H_A_IPHA903_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 4 VAL A 592
ALA A 621
PHE A 654
THR A 658
None
0.39A 4z4hA-5vm9A:
55.9
4z4hA-5vm9A:
79.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z4H_A_IPHA905_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 5 ASP A 538
ALA A 544
LYS A 571
THR A 856
TYR A 858
None
None
A  B   1 ( 2.9A)
None
None
0.63A 4z4hA-5vm9A:
55.9
4z4hA-5vm9A:
79.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z4I_A_IPHA902_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 4 TYR A 655
LYS A 661
GLU A 696
TYR A 699
None
0.80A 4z4iA-5vm9A:
51.5
4z4iA-5vm9A:
79.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z4I_A_IPHA903_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
3 / 3 VAL A 592
ALA A 621
PHE A 654
None
0.32A 4z4iA-5vm9A:
51.5
4z4iA-5vm9A:
79.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z4I_A_IPHA904_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 6 ASP A 538
ALA A 544
LYS A 571
THR A 853
THR A 856
None
None
A  B   1 ( 2.9A)
None
None
0.66A 4z4iA-5vm9A:
51.5
4z4iA-5vm9A:
79.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Z4I_A_IPHA904_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 6 ASP A 538
ALA A 544
LYS A 571
THR A 856
TYR A 858
None
None
A  B   1 ( 2.9A)
None
None
0.59A 4z4iA-5vm9A:
51.5
4z4iA-5vm9A:
79.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZZ8_A_GCSA208_1
(GLUCANASE/CHITOSANAS
E)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 7 GLU A 684
TYR A 705
ASP A 598
ALA A 597
None
1.12A 4zz8A-5vm9A:
undetectable
4zz8A-5vm9A:
9.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5FHZ_A_REAA602_1
(ALDEHYDE
DEHYDROGENASE FAMILY
1 MEMBER A3)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 12 GLY A 411
ARG A 412
THR A 735
LEU A  32
CYH A  36
None
1.48A 5fhzA-5vm9A:
undetectable
5fhzA-5vm9A:
21.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5JS1_A_IPHA901_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 5 TYR A 655
LYS A 661
LEU A 695
GLU A 696
TYR A 699
None
0.81A 5js1A-5vm9A:
59.7
5js1A-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5JS1_A_IPHA902_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
3 / 3 VAL A 592
ALA A 621
PHE A 654
None
0.35A 5js1A-5vm9A:
59.7
5js1A-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KI6_A_IPHA901_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 5 LEU A 651
TYR A 655
LYS A 661
LEU A 695
TYR A 699
None
0.82A 5ki6A-5vm9A:
56.3
5ki6A-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KI6_A_IPHA902_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 4 PHE A 588
VAL A 592
ALA A 621
PHE A 654
None
0.38A 5ki6A-5vm9A:
56.3
5ki6A-5vm9A:
79.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5M50_B_TA1B502_1
(TUBULIN BETA-2B
CHAIN)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 12 VAL A 737
ASP A 738
PRO A  29
ARG A 412
GLY A  27
None
1.49A 5m50B-5vm9A:
undetectable
5m50B-5vm9A:
20.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ND7_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 12 VAL A 123
ASP A  52
PHE A  79
ARG A  64
LEU A  92
None
1.09A 5nd7B-5vm9A:
undetectable
5nd7B-5vm9A:
19.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T7B_A_IPHA901_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
6 / 6 PHE A 588
PRO A 591
VAL A 592
ALA A 621
PHE A 654
THR A 658
None
0.39A 5t7bA-5vm9A:
56.3
5t7bA-5vm9A:
79.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T7B_A_IPHA902_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
7 / 7 LEU A 651
TYR A 655
LYS A 661
PRO A 662
LEU A 695
GLU A 696
TYR A 699
None
0.78A 5t7bA-5vm9A:
undetectable
5t7bA-5vm9A:
79.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5WEA_A_IPHA901_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 5 LEU A 651
LYS A 661
LEU A 695
GLU A 696
None
1.01A 5weaA-5vm9A:
55.7
5weaA-5vm9A:
79.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5WEA_A_IPHA901_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 5 LEU A 651
TYR A 655
LEU A 695
GLU A 696
None
0.80A 5weaA-5vm9A:
55.7
5weaA-5vm9A:
79.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B5V_A_ECLA1001_1
(TRANSIENT RECEPTOR
POTENTIAL CATION
CHANNEL SUBFAMILY V
MEMBER 5)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 7 ILE A 520
PHE A 506
ILE A 467
ALA A 496
None
0.77A 6b5vA-5vm9A:
undetectable
6b5vC-5vm9A:
undetectable
6b5vA-5vm9A:
6.71
6b5vC-5vm9A:
6.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B5V_C_ECLC1001_1
(TRANSIENT RECEPTOR
POTENTIAL CATION
CHANNEL SUBFAMILY V
MEMBER 5)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 7 ILE A 520
PHE A 506
ILE A 467
ALA A 496
None
0.76A 6b5vC-5vm9A:
undetectable
6b5vD-5vm9A:
undetectable
6b5vC-5vm9A:
6.71
6b5vD-5vm9A:
6.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6B5V_D_ECLD1001_1
(TRANSIENT RECEPTOR
POTENTIAL CATION
CHANNEL SUBFAMILY V
MEMBER 5)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 7 ALA A 496
ILE A 520
PHE A 506
ILE A 467
None
0.79A 6b5vB-5vm9A:
undetectable
6b5vD-5vm9A:
undetectable
6b5vB-5vm9A:
6.71
6b5vD-5vm9A:
6.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6CBD_A_TRPA901_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
5 / 5 TYR A 655
LYS A 661
LEU A 695
GLU A 696
TYR A 699
None
1.00A 6cbdA-5vm9A:
57.5
6cbdA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6CBD_A_TRPA902_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 4 VAL A 592
ALA A 621
PHE A 654
PHE A 660
None
0.52A 6cbdA-5vm9A:
57.5
6cbdA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6CBD_A_TRPA903_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 6 ARG A 689
ILE A 693
ILE A 703
ASP A 772
None
1.06A 6cbdA-5vm9A:
57.5
6cbdA-5vm9A:
79.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6CBD_A_TRPA903_0
(PROTEIN ARGONAUTE-2)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 6 CYH A 692
ILE A 693
ILE A 703
ASP A 772
None
0.49A 6cbdA-5vm9A:
57.5
6cbdA-5vm9A:
79.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DWD_D_GLYD713_0
(DEOXYNUCLEOSIDE
TRIPHOSPHATE
TRIPHOSPHOHYDROLASE
SAMHD1)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
3 / 3 ARG A 711
HIS A 712
ARG A 715
A  B   9 ( 4.4A)
None
A  B   7 ( 3.4A)
1.18A 6dwdD-5vm9A:
undetectable
6dwdD-5vm9A:
21.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EXI_A_ADNA503_1
(ADENOSYLHOMOCYSTEINA
SE)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
3 / 3 LEU A 564
GLN A 546
LYS A 555
A  B   2 ( 4.0A)
A  B   1 ( 3.0A)
None
0.68A 6exiB-5vm9A:
2.6
6exiB-5vm9A:
7.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EXI_B_ADNB503_0
(ADENOSYLHOMOCYSTEINA
SE)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
3 / 3 LEU A 564
GLN A 546
LYS A 555
A  B   2 ( 4.0A)
A  B   1 ( 3.0A)
None
0.71A 6exiA-5vm9A:
undetectable
6exiA-5vm9A:
7.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6G2P_A_TRPA502_0
(FLAVIN-DEPENDENT
L-TRYPTOPHAN OXIDASE
VIOA)
5vm9 PROTEIN ARGONAUTE-3
(Homo
sapiens)
4 / 7 ARG A 813
HIS A 817
TYR A 858
VAL A 630
A  B   1 ( 4.9A)
None
None
None
1.31A 6g2pA-5vm9A:
undetectable
6g2pA-5vm9A:
18.65